Loading…
Immediate treatment with Bicalutamide 150 mg as adjuvant therapy significantly reduces the risk of PSA progression in Early Prostate Cancer. Commentary
Saved in:
Published in: | European urology 2003, Vol.44 (5), p.512-518 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | |
---|---|
ISSN: | 0302-2838 1873-7560 |